Literature DB >> 17408259

Pressure-induced phase transitions in PbTiO3: a query for the polarization rotation theory.

J Frantti1, Y Fujioka, R M Nieminen.   

Abstract

Our first-principles computations show that the ground state of PbTiO3 under hydrostatic pressure transforms discontinuously from P4mm to R3c at 9 GPa. Spontaneous polarization decreases with increasing pressure so that the R3c phase transforms to the centrosymmetric Rc phase at around 27 GPa. The first-order phase transition between the tetragonal and rhombohedral phases is exceptional since there is no evidence for a bridging phase. The essential feature of the R3c and Rc phases is that they allow the oxygen octahedron to increase its volume VB at the expense of the cuboctahedral volume VA around a Pb ion. This is further supported by the fact that neither the R3m nor Cm phase, which keep the VA/VB ratio constant, is a ground state within the pressure range between 0 and 40 GPa. Thus, tetragonal strain is dominant up to 9 GPa, whereas at higher pressures, efficient compression through oxygen octahedra tilting plays the central role for PbTiO3. Previously predicted pressure induced colossal enhancement of piezoelectricity in PbTiO3 corresponds to unstable Cm and R3m phases. This suggests that the phase instability, in contrast to the polarization rotation, is responsible for the large piezoelectric properties observed in systems like Pb(Zr,Ti)O3 in the vicinity of the morphotropic phase boundary.

Entities:  

Year:  2007        PMID: 17408259     DOI: 10.1021/jp0713209

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  1 in total

1.  Pressure-induced ferroelectric-like transition creates a polar metal in defect antiperovskites Hg3Te2X2 (X = Cl, Br).

Authors:  Weizhao Cai; Jiangang He; Hao Li; Rong Zhang; Dongzhou Zhang; Duck Young Chung; Tushar Bhowmick; Christopher Wolverton; Mercouri G Kanatzidis; Shanti Deemyad
Journal:  Nat Commun       Date:  2021-03-08       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.